NG
TMO icon

Novem Group’s Thermo Fisher Scientific TMO Stock Holding History

Novem Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-495
Closed -$201K – 447
2025
Q2 		$201K Sell
495
-152
-23% -$63.6K 0.03% 382
2025
Q1 		$322K Buy
647
+78
+14% +$42.2K 0.05% 277
2024
Q4 		$296K Buy
+569
New +$313K 0.04% 288

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Novem Group's TMO Position: Q3 2025 in Review

Novem Group sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 495 shares — an estimated $201K sold.

Novem Group first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $322K in Q1 2025. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Novem Group reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
  • Novem Group sold 495 Thermo Fisher Scientific shares in Q3 2025, an estimated $201K.
  • Novem Group first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
  • Novem Group's Thermo Fisher Scientific position peaked at $322K in Q1 2025.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Novem Group's 13F filing for Q3 2025, filed 10 Nov 2025.